Statin use and pancreatic cancer risk in two prospective cohort studies

BACKGROUND: Statins, 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors, are common lipid-lowering agents and may reduce the risk of several cancer types including pancreatic cancer. However, the association between statin use and pancreatic cancer risk has not been fully evaluated...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:J Gastroenterol
मुख्य लेखकों: Hamada, Tsuyoshi, Khalaf, Natalia, Yuan, Chen, Babic, Ana, Morales-Oyarvide, Vicente, Qian, Zhi Rong, Nowak, Jonathan A., Ng, Kimmie, Kraft, Peter, Rubinson, Douglas A., Stampfer, Meir J., Giovannucci, Edward L., Fuchs, Charles S., Ogino, Shuji, Wolpin, Brian M.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: 2018
विषय:
Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC7609961/
https://ncbi.nlm.nih.gov/pubmed/29362938
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00535-018-1430-x
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन